Four-month-old developed iatrogenic Cushing's syndrome after 6 weeks of intranasal dexamethasone ophthalmic solution.
Acute ozone exposure increases stress hormones and causes alterations in peripheral lipid metabolism in humans.
Both high- and low-dose adrenocorticotropic hormone stimulation tests are adequate for including adrenal insufficiency as a diagnosis.
CT scanning followed by adrenal venous sampling was a cost-effective way to screen for primary aldosteronism.
Higher evening salivary cortisol levels tied to lower brain volume, worse cognitive function in older people.
The stress hormone may play a role in PTSD and anxiety.
All patients using corticosteroid therapy are at risk for adrenal insufficiency, and clinicians should educate patients about this risk.
The etiology of Cushing's syndrome affects how long it takes for a patient to recover their adrenal function after surgery.
Chronocort was effective in treating congenital adrenal hyperplasia in a phase 2 trial.
Higher aldosterone levels are linked to increased parathyroid hormone levels, RAAS inhibitors are associated with lower parathyroid hormone concentrations.
Low levels of dehydroepiandrosterone (DHEA) and its sulfate may predict increased risk for coronary heart disease in men.
Mortality rates are higher among patients with congenital adrenal hyperplasia.
A 33-year-old previously healthy woman, gravida 1, para 0, presented during her first trimester with palpitations and an increase in sweating.
Critical illness alters adrenal glands and contributes to adrenal insufficiency in ICU patients.
Addison disease patients may not benefit from continuous subcutaneous hydrocortisone infusion.
Researchers identify link between poverty during pregnancy and increased cortisol levels in both mothers and their infants.
Patients with adrenal tumors of intermediate phenotype or subclinical Cushing's syndrome are at increased risk of cardiovascular events and mortality compared to those with stable non-secreting adrenal incidentalomas.
A mutation in the PRKACA gene appears to contribute to a rare but severe form of Cushing's syndrome.
Patients with Cushing's syndrome who were administered oral mifepristone (Korlym) daily experienced significant, sustained weight loss over the years as they continued on the medication.
Many patients with adrenal incidentaloma may not receive the necessary care for their condition.
Endocrinology Advisor Articles
- Adjunctive Metformin for Insulin Resistance in T1D: A Clinical Perspective
- Single Blood Sample Highly Predictive for Subsequent Diabetes Diagnosis
- Effect of Fructose, Allulose on Postprandial Glucose Regulation in Type 2 Diabetes
- Sex Hormone Levels May Affect Postmenopausal Heart Disease Risk
- Transgender Youth Not Willing to Delay Hormone Therapy for Fertility Preservation
- Diabetes Treatments
- Metformin May Decrease Colorectal Cancer Risk Among Males With Diabetes
- SGLT2 Inhibitor, GLP-1 Receptor Agonist Combination Treatment for Type 2 Diabetes: Expert Insights
- Semaglutide May Induce Weight Loss in Type 2 Diabetes Despite BMI
- FDA Clears Omnipod DASH System for Diabetes Management
- CDC: Obesity Prevalence Higher in Non-Metropolitan Counties
- Vascular Mortality Declining in Adults With Diabetes in the United States
- Led by AG Sessions, DOJ Declines to Defend ACA Against Federal Lawsuit
- Kidney Function Decline Occurs Nearly Twice as Fast in Diabetes
- Postoperative Radioactive Iodine Ablation Effective in Reducing Disease Recurrence in Low-Risk Thyroid Cancer